vs
Side-by-side financial comparison of CorMedix Inc. (CRMD) and JBG SMITH Properties (JBGS). Click either name above to swap in a different company.
CorMedix Inc. is the larger business by last-quarter revenue ($128.6M vs $127.6M, roughly 1.0× JBG SMITH Properties).
CorMedix Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic products for the prevention and treatment of infectious, inflammatory and cardiorenal diseases. Its lead candidate targets catheter-related bloodstream infections, serving critical care and chronic dialysis patient populations primarily across North America and European markets.
JBG SMITH PropertiesJBGSEarnings & Financial Report
JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.
CRMD vs JBGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $128.6M | $127.6M |
| Net Profit | — | $-23.0M |
| Gross Margin | 83.4% | — |
| Operating Margin | 46.0% | — |
| Net Margin | — | -18.1% |
| Revenue YoY | — | 5.7% |
| Net Profit YoY | — | 57.1% |
| EPS (diluted) | $0.20 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $127.6M | ||
| Q4 25 | $128.6M | $127.6M | ||
| Q3 25 | $104.3M | $123.9M | ||
| Q2 25 | $39.7M | $126.5M | ||
| Q1 25 | $39.1M | $120.7M | ||
| Q4 24 | — | $130.8M | ||
| Q3 24 | — | $136.0M | ||
| Q2 24 | — | $135.3M |
| Q1 26 | — | $-23.0M | ||
| Q4 25 | — | $-45.5M | ||
| Q3 25 | $108.6M | $-28.6M | ||
| Q2 25 | $19.8M | $-19.2M | ||
| Q1 25 | $20.6M | $-45.7M | ||
| Q4 24 | — | $-59.9M | ||
| Q3 24 | — | $-27.0M | ||
| Q2 24 | — | $-24.4M |
| Q1 26 | — | — | ||
| Q4 25 | 83.4% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 95.3% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 46.0% | -47.5% | ||
| Q3 25 | 49.2% | -27.5% | ||
| Q2 25 | 49.2% | -18.4% | ||
| Q1 25 | 51.5% | -44.7% | ||
| Q4 24 | — | -53.6% | ||
| Q3 24 | — | -22.4% | ||
| Q2 24 | — | -24.3% |
| Q1 26 | — | -18.1% | ||
| Q4 25 | — | -35.7% | ||
| Q3 25 | 104.1% | -23.1% | ||
| Q2 25 | 49.9% | -15.2% | ||
| Q1 25 | 52.8% | -37.9% | ||
| Q4 24 | — | -45.8% | ||
| Q3 24 | — | -19.8% | ||
| Q2 24 | — | -18.0% |
| Q1 26 | — | $-0.32 | ||
| Q4 25 | $0.20 | $-0.76 | ||
| Q3 25 | $1.26 | $-0.48 | ||
| Q2 25 | $0.28 | $-0.29 | ||
| Q1 25 | $0.30 | $-0.56 | ||
| Q4 24 | — | $-0.70 | ||
| Q3 24 | — | $-0.32 | ||
| Q2 24 | — | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $148.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $405.3M | — |
| Total Assets | $826.1M | $4.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $148.5M | $75.3M | ||
| Q3 25 | $55.7M | $64.4M | ||
| Q2 25 | $190.7M | $61.4M | ||
| Q1 25 | $77.5M | $81.3M | ||
| Q4 24 | — | $145.8M | ||
| Q3 24 | — | $137.0M | ||
| Q2 24 | — | $163.5M |
| Q1 26 | — | — | ||
| Q4 25 | $405.3M | $1.2B | ||
| Q3 25 | $374.1M | $1.2B | ||
| Q2 25 | $220.6M | $1.3B | ||
| Q1 25 | $114.9M | $1.6B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $2.0B |
| Q1 26 | — | $4.3B | ||
| Q4 25 | $826.1M | $4.4B | ||
| Q3 25 | $750.9M | $4.4B | ||
| Q2 25 | $252.6M | $4.5B | ||
| Q1 25 | $149.6M | $4.7B | ||
| Q4 24 | — | $5.0B | ||
| Q3 24 | — | $5.2B | ||
| Q2 24 | — | $5.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $94.5M | — |
| Free Cash FlowOCF − Capex | $92.7M | — |
| FCF MarginFCF / Revenue | 72.1% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $172.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $94.5M | $73.3M | ||
| Q3 25 | $30.9M | $8.9M | ||
| Q2 25 | $30.0M | $18.8M | ||
| Q1 25 | $19.7M | $12.9M | ||
| Q4 24 | — | $129.4M | ||
| Q3 24 | — | $26.4M | ||
| Q2 24 | — | $23.8M |
| Q1 26 | — | — | ||
| Q4 25 | $92.7M | — | ||
| Q3 25 | $30.4M | — | ||
| Q2 25 | $30.0M | — | ||
| Q1 25 | $19.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 72.1% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 75.4% | — | ||
| Q1 25 | 50.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
JBGS
| Property rental | $105.9M | 83% |
| Third-party real estate services, including reimbursements | $17.2M | 13% |
| Other revenue | $4.5M | 4% |